Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].

Autor: Artemenko AR; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Medical Center «Practical Neurology», Moscow, Russia., Abramov VG; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Bozhenkina TV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Konovalova ZN; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia., Korenko AN; LLC «Professorial Clinic «Oda», St. Petersburg, Russia.; Academian I.P. Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Krasavina DA; LLC «Professorial Clinic «Oda», St. Petersburg, Russia.; Staint Petersburg State Pediatric Medical University, St. Petersburg, Russia., Kurenkov AL; LLC «Medical Center «Practical Neurology», Moscow, Russia.; National Medical Research Center for Children's Health, Moscow, Russia., Latysheva NV; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Naprienko MV; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Orlova OR; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia., Filatova EG; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Shevchenko VS; LLC «Medical Center «Practical Neurology», Moscow, Russia.; Treatment and Rehabilitation Center, Moscow, Russia., Iakovleva PN; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (11), pp. 64-74.

[Analysis of GBA mutations in patients with Parkinson's disease in the Krasnoyarsk region].

Autor: Subbotina TN; Siberian federal university, Krasnoyarsk, Russia.; Federal Siberian Research and Clinical Center, Krasnoyarsk, Russia., Abramov VG; Federal Siberian Research and Clinical Center, Krasnoyarsk, Russia., Shaleva AA; Siberian federal university, Krasnoyarsk, Russia.; Federal Siberian Research and Clinical Center, Krasnoyarsk, Russia., Vereschagina SV; Federal Siberian Research and Clinical Center, Krasnoyarsk, Russia., Pokhabov DV; Federal Siberian Research and Clinical Center, Krasnoyarsk, Russia.; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (4), pp. 103-108.

[Possibilities of non-drug treatment for Parkinson's disease].

Autor: Pokhabov DV; Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia; Siberian Research and Clinical Centre, Krasnoyarsk, Russia., Abramov VG; Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia; Siberian Research and Clinical Centre, Krasnoyarsk, Russia., Pokhabov DD; Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia; Siberian Research and Clinical Centre, Krasnoyarsk, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2016; Vol. 116 (8), pp. 22-29.